Welcome! Please click here if you are interested in learning how Clearity can help in making more informed decisions about ovarian cancer
There are over 20,000 ovarian cancer patients diagnosed in the US each year. This is just 1/10th the number of breast cancer patients. Because of our limited numbers, it is harder to access the resources for new treatments. Although our tumors may look similar under the microscope, they have different molecular profiles or "blueprints." Understanding the blueprint is crucial to finding the appropriate treatments for the future.
The Clearity Foundation is a 501(c)(3) not-for-profit, founded by an ovarian cancer survivor and scientist. We can help you find the right clinical trial through tumor blueprints and can help sponsor payment if it is not covered by insurance.
For a small percentage of newly diagnosed ovarian cancer patients, treatment results in long-term survival and a possible cure, but for the majority of patients a cure is unlikely.
The Clearity Foundation seeks to improve treatment outcomes in recurrent and progressive patients by providing diagnostic services that determine the molecular profile of the individual patient. Having this profile may help match your patient with an appropriate clinical trial or other treatment. We also maintain The Diane Barton Database of results that, over time, may help identify new treatments.